Results 31 to 40 of about 14,571 (197)

Soft tissue tumors: Liposarcoma: Myxoid liposarcoma [PDF]

open access: yes, 2005
Review on Soft tissue tumors: Liposarcoma: Myxoid liposarcoma, with data on clinics, and the genes ...
Sánchez-Garcîa, I   +2 more
core   +1 more source

Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option

open access: yesMolecular Cancer, 2010
Background Myxoid liposarcoma is a relatively common malignant soft tissue tumor, characterized by a (12;16) translocation resulting in a FUS-DDIT3 fusion gene playing a pivotal role in its tumorigenesis.
Szuhai Karoly   +5 more
doaj   +1 more source

Axitinib has antiangiogenic and antitumorigenic activity in myxoid liposarcoma [PDF]

open access: yes, 2016
Myxoid liposarcoma is a rare form of soft-tissue sarcoma. Although most patients initially respond well to treatment, approximately 21% relapse, highlighting the need for alternative treatments.
Kerr, Lauren T.   +7 more
core   +1 more source

The first case of rectal myxoid liposarcoma identified by FUS-DDIT3 fusion, presenting as a submucosal tumor with erosion

open access: yesHuman Pathology: Case Reports, 2018
We experienced a 58-year-old Japanese female complaining of bleedings at defecation for about one year. Endoscopy revealed an Ip submucosal tumor (SMT) at the rectum.
Hiroshi Kono   +7 more
doaj   +1 more source

Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience

open access: yesAsian Journal of Surgery, 2021
Background: To elucidate the clinicopathological features of multiply recurrent retroperitoneal liposarcoma referred to a tertiary center. Methods: We retrospectively analyzed the clinical data of 40 patients with pathologically proven primary ...
Noriyuki Masaki   +5 more
doaj   +1 more source

FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma

open access: yesFrontiers in Oncology, 2022
Myxoid liposarcoma is one of the most common sarcoma entities characterized by FET fusion oncogenes. Despite a generally favorable prognosis of myxoid liposarcoma, chemotherapy resistance remains a clinical problem.
Soheila Dolatabadi   +11 more
doaj   +1 more source

Myxoid liposarcoma of bladder

open access: yesInternational Journal of Surgery Case Reports, 2021
Abstract Introduction Myxoid liposarcoma of the bladder is a rare mesenchymal tumor which is difficult to diagnose and carries a poor prognosis. The primary treatment is complete surgical resection which is usually followed by adjuvant chemotherapy.
Chudal, Sampanna   +5 more
openaire   +2 more sources

An inguinal enigma: Myxoid liposarcoma in a female. [PDF]

open access: yesClin Case Rep, 2023
Myxoid liposarcoma of the inguinal region is rare, can mimics an inguinal hernia. Any swelling in the inguinal region, that is partially reducible, fluctuant, soft, and without any signs of bowel obstruction should be evaluated ...
Agarwal S   +4 more
europepmc   +2 more sources

[Myxoid liposarcoma].

open access: yesRevue medicale de Liege, 2009
Soft-tissue sarcoma is a rare pathology. Due to restricted symptomatology, the diagnosis is often late. Any soft tissues swelling requires at first an ultrasound exam and a radiography, though MRI remains the most appropriate investigation. Treatment will be selected according to the tumor type and its histological grading, these parameters being ...
F, Douchamps, W, Kurth, J M, Crielaard
openaire   +3 more sources

Recurrent massive myxoid liposarcoma in retroperitoneum 10 years post initial operation

open access: yesIJU Case Reports, 2019
Introduction Myxoid liposarcoma tends to be a relatively good prognosis. Follow‐up is recommended once a year from the 5th year after surgery. Case presentation A 48‐year‐old man had a massive retroperitoneal tumor, measuring approximately 20 cm ...
Takamasa Horiuchi   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy